More hope from Japan’s Covid-19 drug, China is still tense

The drug, named S-217622, ​​”shows the ability to rapidly eliminate the SARS-CoV-2 virus that causes Covid-19,” Shionogi & Co announced, citing phase 2b trial data in 3 phase clinical trial.

The data released on April 24 also showed “no major difference in the total score on 12 Covid-19 symptoms between the two experimental groups”, although S-217622 showed an improvement in the total score on 5 symptoms related to “respiratory and fever”, according to Reuters.

Last month, Shionogi & Co announced that it would conduct a worldwide phase 3 clinical trial of S-217622 with support from the US government.

Shionogi & Co CEO Isao Teshirogi confirmed that production could reach 10 million doses per year.

Shionogi & Co will conduct a phase 3 clinical trial of the Covid-19 drug S-217622 worldwide. Photo: Reuters

Meanwhile, the Chinese city of Shanghai recorded 51 Covid-19-related deaths on April 24, up from 39 the day before, according to the city government.

The total number of deaths in the current epidemic wave in Shanghai is 138 people. There are currently 196 patients in critical condition and 23 in serious condition. Also on April 24, Shanghai recorded 16,983 new asymptomatic cases and 2,472 symptomatic cases (compared to 19,657 cases and 1,401 cases on April 23, respectively).

In Beijing, dozens of buildings were blocked in Chaoyang district while residents of this district tested extensively for 3 days, starting from April 25. On April 24, the Chinese capital recorded 19 new cases, including 5 asymptomatic cases.

Chaoyang District, home to 3.45 million people, has asked everyone who works or resides in the area to limit activity.

Residents of Xiaoyang District, Beijing, hoarded essentials on the evening of April 24 for fear that the area would soon be locked down. Photo: Reuters

A school in Chaoyang recorded 10 infections on April 22 and 23. This school has been locked down.

All drivers and tour guides of tour operators organizing urban tours within the 14 days before April 24 have been asked to take nucleic acid tests and work from home until the results are available. fruit.

Among those who have tested positive so far are students, tourists and workers working in the field of interior decoration. Therefore, the risk of infection is still high, and the number of Covid-19 cases is likely to increase in the coming days, said Pang Xinghuo, deputy director of the Beijing Center for Disease Control and Prevention.